Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2026-05-15 @ 7:56 AM
Study NCT ID:
NCT01617967
Status:
COMPLETED
Last Update Posted:
2024-04-19
First Post:
2012-06-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Tolerability of Patisiran (ALN-TTR02) in Transthyretin (TTR) Amyloidosis
Sponsor:
Organization: